<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<style><!--
/* Font Definitions */
@font-face
{font-family:Wingdings;
panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0cm;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri",sans-serif;
mso-fareast-language:EN-US;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
{mso-style-priority:34;
margin-top:0cm;
margin-right:0cm;
margin-bottom:0cm;
margin-left:36.0pt;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri",sans-serif;
mso-fareast-language:EN-US;}
p.msonormal0, li.msonormal0, div.msonormal0
{mso-style-name:msonormal;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman",serif;}
span.EmailStyle19
{mso-style-type:personal-compose;
font-family:"Calibri",sans-serif;
color:windowtext;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;
font-family:"Calibri",sans-serif;
mso-fareast-language:EN-US;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
{page:WordSection1;}
/* List Definitions */
@list l0
{mso-list-id:1380006835;
mso-list-type:hybrid;
mso-list-template-ids:-435415930 134807553 134807555 134807557 134807553 134807555 134807557 134807553 134807555 134807557;}
@list l0:level1
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Symbol;}
@list l0:level2
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:"Courier New";}
@list l0:level3
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Wingdings;}
@list l0:level4
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Symbol;}
@list l0:level5
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:"Courier New";}
@list l0:level6
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Wingdings;}
@list l0:level7
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Symbol;}
@list l0:level8
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:"Courier New";}
@list l0:level9
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Wingdings;}
@list l1
{mso-list-id:1929993847;
mso-list-type:hybrid;
mso-list-template-ids:2011340020 134807553 134807555 134807557 134807553 134807555 134807557 134807553 134807555 134807557;}
@list l1:level1
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Symbol;}
@list l1:level2
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:"Courier New";}
@list l1:level3
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Wingdings;}
@list l1:level4
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Symbol;}
@list l1:level5
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:"Courier New";}
@list l1:level6
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Wingdings;}
@list l1:level7
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Symbol;}
@list l1:level8
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:"Courier New";}
@list l1:level9
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Wingdings;}
ol
{margin-bottom:0cm;}
ul
{margin-bottom:0cm;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-GB" link="blue" vlink="purple">
<div class="WordSection1">
<p class="MsoNormal">Dear colleagues,<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">I would like to invite you to submit an abstract and register for the upcoming conference on
<i>Systems Epigenetics - Towards Precision Cancer Medicine</i> in Amsterdam, 27-30 November 2018. Abstracts on novel methods and applications of computational approaches to the analysis of epigenomics data are especially welcomed.
<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><b><u>Systems Epigenetics - Towards Precision Cancer Medicine<o:p></o:p></u></b></p>
<p class="MsoListParagraph" style="text-indent:-18.0pt;mso-list:l1 level1 lfo2"><![if !supportLists]><span style="font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt "Times New Roman"">
</span></span></span><![endif]><b>Date</b>: 27-30 November, 2018<o:p></o:p></p>
<p class="MsoListParagraph" style="text-indent:-18.0pt;mso-list:l1 level1 lfo2"><![if !supportLists]><span style="font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt "Times New Roman"">
</span></span></span><![endif]><b>Location</b>: Amsterdam, the Netherlands<o:p></o:p></p>
<p class="MsoListParagraph" style="text-indent:-18.0pt;mso-list:l1 level1 lfo2"><![if !supportLists]><span lang="NL" style="font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt "Times New Roman"">
</span></span></span><![endif]><b><span lang="NL">Website</span></b><span lang="NL">:
<a href="http://www.SystemsEpigenetics2018.eu">http://www.SystemsEpigenetics2018.eu</a><o:p></o:p></span></p>
<p class="MsoListParagraph" style="text-indent:-18.0pt;mso-list:l1 level1 lfo2"><![if !supportLists]><span style="font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt "Times New Roman"">
</span></span></span><![endif]><b>Registration</b>: <a href="http://systemsepigenetics2018.eu/registration">
http://systemsepigenetics2018.eu/registration</a> (early bird till <b>September 23</b>)<o:p></o:p></p>
<p class="MsoListParagraph" style="text-indent:-18.0pt;mso-list:l1 level1 lfo2"><![if !supportLists]><span style="font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt "Times New Roman"">
</span></span></span><![endif]><b>Call for abstracts</b> (short talks/posters): <a href="http://www.systemsepigenetics2018.eu/call-for-abstracts">
http://www.systemsepigenetics2018.eu/call-for-abstracts</a> (deadline <b>October 14</b>)<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">We will discuss various aspects of epigenetic regulation (e.g. higher order chromatin folding, chromatin enhancer regulation, dynamics of chromatin and nuclear organization and epigenomics) in the context of cancer initiation, progression
and treatment. The latest scientific developments to studying epigenetic regulation will be presented by keynote and invited speakers setting ground for precision medicine in cancer treatment. This conference brings together scientists from multidisciplinary
fields employing different research strategies providing a platform for scientists focusing on fundamental and biomedical research, clinicians and private sector scientists. We aim to create a vibrant environment to promote cross-talk between different disciplines.<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><b><u>Confirmed speakers<o:p></o:p></u></b></p>
<p class="MsoNormal">Geneviève Almouzni, Institut Curie, FR<o:p></o:p></p>
<p class="MsoNormal">Jonathan Chubb, University College London, MRC, GB<o:p></o:p></p>
<p class="MsoNormal">Martin Fussenegger, ETH Zürich, CH<o:p></o:p></p>
<p class="MsoNormal">Pamela Munster, University of California, San Francisco, US<o:p></o:p></p>
<p class="MsoNormal">Lucia Altucci, Institute of Genetics and Biophysics, IT<o:p></o:p></p>
<p class="MsoNormal">Pilar Blancafort, University of Western Australia, AU<o:p></o:p></p>
<p class="MsoNormal">Tiziana Bonaldi, European Institute of Oncology, SRSI, IT<o:p></o:p></p>
<p class="MsoNormal">Maria Carmo-Fonseca, Instituto de Medicina Molecular Lisbon, PT<o:p></o:p></p>
<p class="MsoNormal">Toni Cathomen, University Medical Center Freiburg, DE<o:p></o:p></p>
<p class="MsoNormal">Luciano Di Croce, Centre for Genomic Regulation, ES<o:p></o:p></p>
<p class="MsoNormal"><span lang="NL">Wouter de Laat, Hubrecht Institute, NL<o:p></o:p></span></p>
<p class="MsoNormal">Massimo Loda, Harvard Cancer Center, US<o:p></o:p></p>
<p class="MsoNormal">Luca Magnani, Imperial College London, GB<o:p></o:p></p>
<p class="MsoNormal">Christoph Plass, German Cancer Research Center, DE<o:p></o:p></p>
<p class="MsoNormal">Maria Rodriguez Martinez, IBM Research, CH<o:p></o:p></p>
<p class="MsoNormal">Paola Scaffidi, Francis Crick institute London, GB<o:p></o:p></p>
<p class="MsoNormal">Vahid Shahrezaei, Imperial College London, GB<o:p></o:p></p>
<p class="MsoNormal"><span lang="NL">Henk Stunnenberg, Radboud University Nijmegen, NL<o:p></o:p></span></p>
<p class="MsoNormal">Lodewyk Wessels, Netherlands Cancer Institute, NL<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><b><u>Call for Abstracts<o:p></o:p></u></b></p>
<p class="MsoNormal">Abstracts can be <a href="http://www.systemsepigenetics2018.eu/call-for-abstracts">
submitted</a> for a short talk or poster within one of the following session categories:<o:p></o:p></p>
<p class="MsoListParagraph" style="text-indent:-18.0pt;mso-list:l0 level1 lfo4"><![if !supportLists]><span style="font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt "Times New Roman"">
</span></span></span><![endif]>Epigenetic regulatory mechanisms: 'State-of-the-art epigenetics'<o:p></o:p></p>
<p class="MsoListParagraph" style="text-indent:-18.0pt;mso-list:l0 level1 lfo4"><![if !supportLists]><span style="font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt "Times New Roman"">
</span></span></span><![endif]>Epigenetics and clinical cancer: A systems medicine view<o:p></o:p></p>
<p class="MsoListParagraph" style="text-indent:-18.0pt;mso-list:l0 level1 lfo4"><![if !supportLists]><span style="font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt "Times New Roman"">
</span></span></span><![endif]>Epigenetics and clinical cancer: metabolic reprogramming<o:p></o:p></p>
<p class="MsoListParagraph" style="text-indent:-18.0pt;mso-list:l0 level1 lfo4"><![if !supportLists]><span style="font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt "Times New Roman"">
</span></span></span><![endif]>Epigenetics, cell heterogeneity and cancer stem cells<o:p></o:p></p>
<p class="MsoListParagraph" style="text-indent:-18.0pt;mso-list:l0 level1 lfo4"><![if !supportLists]><span style="font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt "Times New Roman"">
</span></span></span><![endif]>Innovative epigenetic interference tools and synthetic biology<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">---<o:p></o:p></p>
<p class="MsoNormal">Perry Moerland, PhD<o:p></o:p></p>
<p class="MsoNormal">Room J1B-210-1<o:p></o:p></p>
<p class="MsoNormal">Bioinformatics Laboratory, Department of Clinical Epidemiology, Biostatistics and Bioinformatics<o:p></o:p></p>
<p class="MsoNormal">Academic Medical Center, University of Amsterdam <o:p></o:p></p>
<p class="MsoNormal">Postbus 22660, 1100 DD Amsterdam, The Netherlands<o:p></o:p></p>
<p class="MsoNormal">tel: +31 20 5666945<o:p></o:p></p>
<p class="MsoNormal"><a href="mailto:p.d.moerland@amc.uva.nl"><span style="color:blue">p.d.moerland@amc.uva.nl</span></a>,
<a href="http://www.bioinformaticslaboratory.nl/"><span style="color:blue">http://www.bioinformaticslaboratory.nl/</span></a><o:p></o:p></p>
<p class="MsoNormal"><span style="mso-fareast-language:EN-GB"><o:p> </o:p></span></p>
<p class="MsoNormal"><o:p> </o:p></p>
</div>
<div style="font-size:9pt; font-family: 'Calibri',sans-serif;">
<p style="font-size:8pt; line-height:4pt; font-family: 'Arial','times roman',serif;">
</p>
<hr>
<p style="text-align: center;">AMC Disclaimer : https://www.amc.nl/disclaimer</p>
<hr>
<p style="font-size:8pt; line-height:4pt; font-family: 'Arial','times roman',serif;">
</p>
</div>
</body>
</html>